Table 1 Baseline characteristics of 19924 hypertensive patients according to the trajectories of TyG index from 2006 to 2010
Variables | Low-Stable | Moderate low-stable | Moderate high-stable | Elevated-stable | Elevated-increasing | P |
|---|---|---|---|---|---|---|
N | 2483 | 9666 | 5759 | 1741 | 275 | – |
Age, years | 59.38 ± 11.35 | 57.29 ± 11.35 | 55.76 ± 10.71 | 54.49 ± 10.13 | 51.88 ± 9.29 |  < 0.01 |
Male n (%) | 2029 (81.72) | 7886 (81.58) | 4708 (81.75) | 1478 (84.89) | 241 (87.64) |  < 0.01 |
Heart rate, beats/min | 72.72 ± 10.62 | 73.97 ± 10.91 | 75.51 ± 11.29 | 77.89 ± 11.77 | 78.69 ± 10.54 |  < 0.01 |
BMI, kg/m2 | 24.31 ± 3.27 | 25.61 ± 3.33 | 26.68 ± 3.31 | 26.99 ± 3.29 | 27.01 ± 3.30 |  < 0.01 |
SBP, mmHg | 140.83 ± 19.51 | 140.69 ± 19.11 | 142.21 ± 18.73 | 143.69 ± 19.16 | 142.43 ± 17.13 |  < 0.01 |
DBP, mmHg | 87.89 ± 10.71 | 88.89 ± 10.71 | 90.09 ± 10.68 | 90.93 ± 11.11 | 91.65 ± 10.38 |  < 0.01 |
Total cholesterol, mmol/L | 4.67 ± 0.87 | 4.95 ± 0.92 | 5.23 ± 1.03 | 5.43 ± 1.17 | 6.44 ± 1.79 |  < 0.01 |
hs-CRP, mmol/L | 1.26 (0.62, 3.01) | 1.04 (0.40, 2.60) | 1.30 (0.50, 3.10) | 1.60 (0.70, 3.70) | 1.61 (0.90, 3.72) |  < 0.01 |
TyG in 2006 | 7.94 ± 0.34 | 8.55 ± 0.37 | 9.22 ± 0.44 | 9.84 ± 0.52 | 10.45 ± 0.60 |  < 0.01 |
TyG in 2008 | 7.91 ± 0.32 | 8.56 ± 0.36 | 9.15 ± 0.42 | 9.87 ± 0.53 | 10.67 ± 0.63 |  < 0.01 |
TyG in 2010 | 7.97 ± 0.32 | 8.53 ± 0.38 | 9.13 ± 0.44 | 9.81 ± 0.49 | 10.86 ± 0.61 |  < 0.01 |
Current smoker, n (%) | 800 (32.22) | 3416 (35.34) | 2251 (39.09) | 794 (45.61) | 136 (49.45) |  < 0.01 |
Current drinker, n (%) | 698 (28.11) | 2983 (30.86) | 2126 (36.92) | 761 (43.71) | 134 (48.73) |  < 0.01 |
Active physical activity, n (%) | 415 (16.71) | 1573 (16.27) | 865 (15.02) | 230 (13.21) | 42 (15.27) |  < 0.01 |
Senior high school or above, n (%) | 351 (14.14) | 1865 (19.29) | 1240 (21.53) | 376 (21.60) | 64 (23.27) |  < 0.01 |
Atrial fibrillation, n (%) | 33 (1.33) | 90 (0.93) | 43 (0.75) | 10 (0.57) | 0 (0.00) | 0.02 |
Diabetes mellitus, n (%) | 47 (1.89) | 648 (6.70) | 1296 (22.50) | 793 (45.55) | 176 (64.01) |  < 0.01 |
Hypoglycemic drugs, n (%) | 19 (0.77) | 231 (2.39) | 482 (8.37) | 284 (16.31) | 65 (23.64) |  < 0.01 |
Anti-hypertensive drugs, n (%) | 449 (18.08) | 1969 (20.37) | 1487 (25.82) | 504 (28.95) | 103 (37.45) |  < 0.01 |
Lipid-lowering drugs, n (%) | 9 (0.36) | 82 (0.85) | 114 (1.98) | 53 (3.04) | 13 (4.73) |  < 0.01 |